Literature DB >> 18446685

Adrenocortical dysfunction in obesity and the metabolic syndrome.

A W Krug1, M Ehrhart-Bornstein.   

Abstract

Recently, it has become evident that the adrenals play a key role in obesity as well as in the metabolic syndrome and their complications. On the one hand, adrenal steroids are involved in physiological regulation of adipose tissue and energy homeostasis and in the pathogenesis of cardiometabolic complications. On the other hand, fat cell-derived factors, adipocytokines, and lipids released from adipose tissue are involved in the modulation of adrenal steroidogenesis. Aldosterone plasma levels are elevated in obesity and in patients with the metabolic syndrome. Recent research has provided evidence that adipocytes secrete factors that stimulate adrenal mineralocorticoid release and sensitize the adrenal cortex to angiotensin II.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18446685     DOI: 10.1055/s-2008-1073154

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  4 in total

Review 1.  Glucocorticoid-induced hypertension.

Authors:  Julie E Goodwin; David S Geller
Journal:  Pediatr Nephrol       Date:  2011-07-09       Impact factor: 3.714

2.  Mineralocorticoid receptor antagonism prevents obesity-induced cerebral artery remodeling and reduces white matter injury in rats.

Authors:  Paulo W Pires; Jonathon L McClain; Sebastian F Hayoz; Anne M Dorrance
Journal:  Microcirculation       Date:  2018-06-07       Impact factor: 2.628

3.  Changes in morphology and function of adrenal cortex in mice fed a high-fat diet.

Authors:  M M Swierczynska; I Mateska; M Peitzsch; S R Bornstein; T Chavakis; G Eisenhofer; V Lamounier-Zepter; S Eaton
Journal:  Int J Obes (Lond)       Date:  2014-06-12       Impact factor: 5.095

4.  Insulin Regulates Adrenal Steroidogenesis by Stabilizing SF-1 Activity.

Authors:  Ann W Kinyua; Khanh V Doan; Dong Joo Yang; My Khanh Q Huynh; Yun-Hee Choi; Dong Min Shin; Ki Woo Kim
Journal:  Sci Rep       Date:  2018-03-22       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.